Cabozantinib/atezolizumab phase 3 combo trial launched in renal cell carcinomaJuly 20th 2020
The phase 3 CONTACT-03 trial is exploring the combination of the multikinase inhibitor and immunotherapy agent in patients with renal cell carcinoma after exposure to an immune-checkpoint inhibitor.
No survival falloff with use of minimally invasive surgery in early-stage kidney cancerJuly 13th 2020
Minimally invasive surgery was associated with similar overall survival and disease-specific survival outcomes compared with open surgery in patients with early-stage kidney cancer.
Ablative RT could be alternative for solitary-kidney RCCNovember 7th 2018
“We believe that referral for kidney SABR is worthy of consideration in patients with solitary-kidney RCC who are faced with limited and risky management options,” says researcher Rohann Correa, MD, PhD.
Challenging case: A large ‘ticking’ back lipoma and a small renal massOctober 23rd 2018
The authors discuss the case of a 57-year-old man who initially presents to a general surgeon with a chief complaint of right lower back and posterior neck pain, with associated soft tissue swelling. On presentation to the authors' institution, he had experienced regrowth of the masses with "ticking" in the right lumbar area that he correlated with his heartbeat. He also reported unintentional weight loss of 15 pounds over the previous 3 months.
What do you like/dislike about practicing in your state?August 28th 2018
“Florida, specifically South Florida, is a very tough place to practice. There’s a fairly prominent infiltration of Medicare HMOs with a lot of obstruction to doing anything for the patient that’s necessary," says one urologist.
Checkpoint inhibitor shows efficacy in elderly patientsJuly 31st 2018
Retrospective analyses of data collected in a real-world study provide assurance about using nivolumab (Opdivo) to treat elderly patients with metastatic renal cell carcinoma who have failed previous therapy.